Sandra Ciesek
#9,633
Most Influential Person Now
German virologist
Sandra Ciesek's AcademicInfluence.com Rankings
Sandra Ciesekbiology Degrees
Biology
#504
World Rank
#887
Historical Rank
Virology
#5
World Rank
#5
Historical Rank
Download Badge
Biology
Sandra Ciesek's Degrees
- Doctorate Medicine University of Marburg
- PhD Virology University of Marburg
Why Is Sandra Ciesek Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sandra Ciesek is a German physician and virologist. She is the director of the Institute of Medical Virology at the Universitätsklinikum Frankfurt and professor of medical virology at the Goethe University Frankfurt. Her main areas of research include new forms of therapy for hepatitis C and, more recently, the search for drugs against COVID-19.
Sandra Ciesek's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Proteomics of SARS-CoV-2-infected host cells reveals therapy targets (2020) (708)
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity (2020) (623)
- Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China (2020) (559)
- Mapping the human genetic architecture of COVID-19 (2021) (455)
- A lymphotoxin-driven pathway to hepatocellular carcinoma. (2009) (350)
- Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies (2021) (305)
- The green tea polyphenol, epigallocatechin‐3‐gallate, inhibits hepatitis C virus entry (2011) (259)
- Detection of SARS-CoV-2 in raw and treated wastewater in Germany – Suitability for COVID-19 surveillance and potential transmission risks (2020) (244)
- Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes (2010) (224)
- Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease (2020) (222)
- Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. (2010) (186)
- The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry (2014) (174)
- Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays (2020) (164)
- Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication (2020) (149)
- SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes (2020) (146)
- Lack of antiviral activity of darunavir against SARS-CoV-2 (2020) (123)
- The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro (2021) (121)
- Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A (2009) (118)
- Clinical performance of different SARS‐CoV‐2 IgG antibody tests (2020) (109)
- Inactivation and survival of hepatitis C virus on inanimate surfaces. (2011) (100)
- Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany (2011) (95)
- Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. (2009) (95)
- Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread? (2020) (95)
- How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides. (2010) (86)
- An action plan for pan-European defence against new SARS-CoV-2 variants (2021) (86)
- SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission (2020) (86)
- Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates (2022) (85)
- Glucocorticosteroids increase cell entry by hepatitis C virus. (2010) (79)
- Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes (2022) (77)
- Aprotinin Inhibits SARS-CoV-2 Replication (2020) (75)
- Hepatitis in 2010: The dawn of a new era in HCV therapy (2011) (74)
- SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles (2020) (67)
- GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection (2019) (66)
- Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection (2020) (66)
- Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections (2020) (64)
- Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs (2020) (63)
- Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment. (2013) (62)
- Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020 (2020) (59)
- Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q (2021) (57)
- SARS-CoV-2 infected host cell proteomics reveal potential therapy targets (2020) (56)
- Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies (2022) (52)
- Influenza virus infection as precipitating event of acute-on-chronic liver failure. (2019) (51)
- A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection (2021) (51)
- Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells. (2019) (51)
- Bamlanivimab does not neutralize two SARS-CoV-2 variants carrying E484K in vitro (2021) (48)
- Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles (2011) (46)
- Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples (2020) (46)
- Assessment of SARS-CoV-2 Transmission on an International Flight and Among a Tourist Group (2020) (45)
- Host cell mTORC1 is required for HCV RNA replication (2015) (44)
- Immunosuppression, liver injury and post‐transplant HCV recurrence (2012) (44)
- Inactivation of hepatitis C virus infectivity by human breast milk. (2013) (43)
- Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re‐infection after liver transplantation (2016) (43)
- Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factors. (2011) (41)
- Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1. (2012) (41)
- Analysis of humoral immune responses in SARS-CoV-2 infected patients (2020) (40)
- Hepatitis C virus enters human peripheral neuroblastoma cells – evidence for extra‐hepatic cells sustaining hepatitis C virus penetration (2011) (35)
- Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies (2021) (35)
- Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (2020) (35)
- Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication (2015) (33)
- 48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection (2020) (33)
- Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells (2020) (32)
- Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication. (2012) (32)
- Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver. (2008) (31)
- Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection (2021) (30)
- Second-wave protease inhibitors: choosing an heir. (2011) (30)
- Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection (2021) (29)
- Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load. (2017) (28)
- Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients. (2006) (27)
- A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model (2021) (27)
- Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity (2020) (26)
- Hepatitis C virus core antigen testing in liver and kidney transplant recipients (2014) (26)
- SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment (2022) (25)
- In vitro activity of itraconazole against SARS‐CoV‐2 (2020) (25)
- Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion (2020) (25)
- Primary Biliary Acids Inhibit Hepatitis D Virus (HDV) Entry into Human Hepatoma Cells Expressing the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) (2015) (25)
- Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings (2020) (24)
- Infectivity of deceased COVID-19 patients (2021) (24)
- Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5 (2022) (24)
- Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma (2021) (23)
- S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11) (2021) (23)
- Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro (2021) (22)
- At-home self-testing of teachers with a SARS-CoV-2 rapid antigen test to reduce potential transmissions in schools (2020) (22)
- Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants (2021) (22)
- Novel multiple swab method enables high efficiency in SARS‐CoV‐2 screenings without loss of sensitivity for screening of a complete population (2020) (22)
- COVID-19-Related Coagulopathy—Is Transferrin a Missing Link? (2020) (21)
- Impaired TRAIL‐dependent cytotoxicity of CD1c‐positive dendritic cells in chronic hepatitis C virus infection (2007) (21)
- Membranous Budd–Chiari syndrome in Caucasians (2010) (20)
- Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs) (2021) (20)
- Inhibition of papain-like protease PLpro blocks SARS-CoV-2 spread and promotes anti-viral immunity (2020) (18)
- Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area (2020) (18)
- Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy (2021) (17)
- Effects of cyclosporine on human dendritic cell subsets. (2005) (17)
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity (2020) (17)
- FACT- Frankfurt adjusted COVID-19 testing- a novel method enables high-throughput SARS-CoV-2 screening without loss of sensitivity (2020) (16)
- Clinical Outcome and Viral Genome Variability of Hepatitis B Virus–Induced Acute Liver Failure (2019) (16)
- Characterization of the inhibition of hepatitis C virus entry by In vitro–generated and patient‐derived oxidized low‐density lipoprotein (2013) (16)
- RNA reference materials with defined viral RNA loads of SARS-CoV-2—A useful tool towards a better PCR assay harmonization (2022) (16)
- A rare cause of nonalcoholic fatty liver disease. (2006) (16)
- Targeting pentose phosphate pathway for SARS-CoV-2 therapy (2020) (15)
- Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy (2016) (15)
- Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus (2019) (15)
- Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform (2022) (15)
- Role of BK polyomavirus (BKV) and Torque teno virus (TTV) in liver transplant recipients with renal impairment (2018) (15)
- The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype (2022) (15)
- Thirty years of CMV seroprevalence—a longitudinal analysis in a German university hospital (2020) (13)
- Longitudinal testing for respiratory and gastrointestinal shedding of SARS-CoV-2 in day care centres in Hesse, Germany (2020) (13)
- Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication (2021) (13)
- New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations (2021) (13)
- Automated Nucleic Acid Isolation Methods for HDV viral Load Quantification can Lead to viral Load Underestimation (2019) (13)
- Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure (2021) (13)
- Detailed stratified GWAS analysis for severe COVID-19 in four European populations (2022) (13)
- Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7 (2021) (12)
- Clinical course and core variability in HBV infected patients without detectable anti-HBc antibodies. (2017) (12)
- Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections. (2019) (12)
- Cyclophilin polymorphism and virus infection (2015) (11)
- Assessment of SARS-CoV-2 Transmission on an International Flight and Among a Tourist Group. (2020) (11)
- Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage (2021) (11)
- Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological Processes (2020) (10)
- Single- and multiple-dose pharmacokinetics of ethambutol and rifampicin in a tuberculosis patient with acute respiratory distress syndrome undergoing extended daily dialysis and ECMO treatment. (2016) (10)
- Longitudinal Testing for Respiratory and Gastrointestinal Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Day Care Centers in Hesse, Germany (2021) (10)
- Impact of immune suppressive agents on the BK‐Polyomavirus non coding control region (2018) (9)
- A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection (2017) (9)
- The Novel Immunosuppressive Protein Kinase C Inhibitor Sotrastaurin Has No Pro-Viral Effects on the Replication Cycle of Hepatitis B or C Virus (2011) (9)
- Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body Fluids (2018) (9)
- Implementierung eines Betriebskonzeptes in einer HNO-Klinik im Rahmen der SARS-CoV-2-Pandemie (2020) (9)
- Prolonged survival of hepatitis C virus in the anesthetic propofol. (2011) (9)
- Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro (2021) (9)
- Methylene Blue Treatment of Grafts During Cold Ischemia Time Reduces the Risk of Hepatitis C Virus Transmission (2018) (8)
- Anti-parietal cell autoantibodies (PCA) in primary biliary cirrhosis: a putative marker for recurrence after orthotopic liver transplantation? (2010) (8)
- Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators (2015) (8)
- Comprehensive Evaluation of Hepatitis E Serology and Molecular Testing in a Large Cohort (2020) (8)
- Landscape of T‐cell repertoires with public COVID‐19‐associated T‐cell receptors in pre‐pandemic risk cohorts (2021) (8)
- Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study. (2021) (7)
- Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response (2022) (7)
- Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma (2022) (7)
- Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice (2022) (7)
- Incorporation of primary patient‐derived glycoproteins into authentic infectious hepatitis C virus particles (2014) (7)
- Detection and infectivity of SARS-CoV-2 in exhumated corpses (2021) (7)
- A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization (2021) (7)
- The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase. (2008) (7)
- Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization. (2014) (7)
- The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation. (2019) (7)
- COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view (2021) (7)
- A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis (2021) (7)
- Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches (2010) (7)
- Die Virologie von SARS-CoV-2 (2020) (6)
- [SARS-CoV-2/COVID-19: systematic review of requirements for personal protective equipment in primary patient contact and organization of the operating area]. (2020) (6)
- Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response (2022) (6)
- Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia (2022) (6)
- Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation (2022) (6)
- Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures (2022) (6)
- HBV reactivation in allogeneic stem cell transplant recipients: Risk factors, outcome, and role of hepatitis B virus mutations (2017) (6)
- Characterization of ACE Inhibitors and AT1R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model (2021) (6)
- Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes (2022) (6)
- Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour (2021) (6)
- Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors (2019) (6)
- SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination (2022) (6)
- SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations. (2019) (6)
- Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C Infection (2015) (5)
- Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection (2022) (5)
- 333 KINETICS OF HCV CORE ANTIGEN DURING ANTIVIRAL TREATMENT OF ACUTE AND CHRONIC HEPATITIS C AS DETERMINED BY A NOVEL CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (2009) (5)
- Characterization of the humoral immune response to BNT162b2 in elderly residents of long-term care facilities five to seven months after vaccination (2021) (5)
- [Implementation of an operational concept in an ENT clinic in the context of the SARS-CoV-2 pandemic]. (2020) (4)
- SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach (2022) (4)
- Powered air-purifying respirators used during the SARS-CoV-2 pandemic significantly reduce speech perception (2021) (4)
- [Suspicion of a newly appearing hypertrophic obstructive cardiomyopathy in a patient treated for hepatocellular carcinoma]. (2008) (4)
- Perioperative White Blood Cell Count as a Marker for Patient and GraftSurvival after Orthotopic Liver Transplantation (2015) (4)
- Cationic amphiphilic drugs enhance entry of lentiviral particles pseudotyped with rabies virus glycoprotein into non-neuronal cells. (2015) (4)
- Low But Recoverable Markers of Humoral Immune Response to BNT162b2 in Elderly LTCF Residents Five to Seven Months After Two-Dose Vaccination (2022) (4)
- Stability and transmission of hepatitis C virus in different anesthetic agents. (2013) (4)
- [Retroperitoneal abscess in a man with severe necrotizing pancreatitis]. (2006) (4)
- Clinical patterns associated with the concurrent detection of anti‐HBs and HBV DNA (2018) (4)
- 48 ENHANCEMENT OF HEPATITIS C VIRUS ENTRY BY STEROIDS (2009) (4)
- Clinical and Virological Aspects of HBV Reactivation: A Focus on Acute Liver Failure (2019) (4)
- Folgeerkrankungen nach Organtransplantation (2006) (4)
- Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens (2020) (3)
- Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies (2022) (3)
- High-Frequency Self-Testing by Schoolteachers for Sars-Cov-2 Using a Rapid Antigen Test. (2021) (3)
- Wastewater surveillance allows early detection of SARS-CoV-2 omicron in North Rhine-Westphalia, Germany (2022) (3)
- Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater (2022) (3)
- TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection (2022) (3)
- Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients (2022) (3)
- Author response for "A pair of non‐competing neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model" (2021) (3)
- Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infection (2021) (2)
- Verdacht auf neu aufgetretene hypertrophe obstruktive Kardiomyopathie bei hepatozellulärem Karzinom (2008) (2)
- HBV reactivation in allogeneic stem cell transplant recipients: risk factors, outcome and role of HBV mutations (2018) (2)
- Drug Sensitivity of Currently Circulating Mpox Viruses. (2022) (2)
- The COVID-19 PHARMACOME: Rational Selection of Drug Repurposing Candidates from Multimodal Knowledge Harmonization (2020) (2)
- Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro. (2012) (2)
- Early Detection of SARS-CoV-2 Omicron BA.4/5 in German wastewater (2022) (2)
- Safety and Efficacy of 10 mg Myrcludex B/IFNa Combination Therapy in Patients with Chronic HBV/HDV Co-Infection (2020) (2)
- Exposure to BA.4/BA.5 Spike glycoprotein drives pan-Omicron neutralization in vaccine-experienced humans and mice (2022) (2)
- SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression (2022) (2)
- A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated (2021) (2)
- Nachhaltige Strategien gegen die COVID-19-Pandemie in Deutschland im Winter 2021/2022 (2021) (2)
- High-frequency self-testing of schoolteachers for SARS-CoV- 2 with a rapid antigen test: findings of the Safe School Hesse study (2021) (2)
- P0051 : Perioperative white blood cell count as a marker for patient and graft survival after orthotopic liver transplantation (2015) (2)
- Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections (2022) (2)
- Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease (2021) (2)
- [Hepatitis C virus cell culture models--new perspectives for research and clinic]. (2008) (1)
- SARS-CoV-2 Vaccination in Kidney Transplant Recipients—Stratified Analysis of the Humoral Immune Response (2022) (1)
- Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model (2022) (1)
- Efficient inactivation of pseudotyped HIV-based lentiviral vectors and infectious HIV. (2019) (1)
- A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection (2021) (1)
- Infectivity and stability of hepatitis C virus in different perfusion solutions (2019) (1)
- Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination (2022) (1)
- Expression Cloning of Host Factors Required for the HCV Replication Cycle. (2018) (1)
- 1204 THE PEPSI PROJECT: HCV RESISTANCE SCREENING AND PREDICTION OF PI-CONTAINING THERAPY OUTCOME (2013) (1)
- Longitudinal testing for SARS-CoV-2 RNA in day care centers in Hesse, Germany, during increased local incidence and with VOC Alpha as dominant variant: Results of the SAFE KiDS 2 and SAFE KiDS 3 study (2021) (1)
- CD47 as a potential biomarker for the early diagnosis of severe COVID-19 (2021) (1)
- COVID‐19 among children seeking primary paediatric care with signs of an acute infection (2021) (1)
- Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer (2022) (1)
- An appeal for strengthening genomic pathogen surveillance to improve pandemic preparedness and infection prevention: the German perspective (2023) (1)
- Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics (2022) (1)
- [Sequelae of organ transplantation]. (2006) (1)
- Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line (2021) (1)
- [Establishment of genomic pathogen surveillance to strengthen pandemic preparedness and infection prevention in Germany]. (2023) (1)
- The Relapse Phenomenon in Mild COVID Treated With Nirmatrelvir/Ritonavir in an Immunocompetent Patient. (2022) (1)
- A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection (2022) (1)
- 1020 EPIDEMIOLOGICAL TRENDS IN INCIDENCE AND MORTALITY OF HEPATOBILIARY CANCERS IN GERMANY (2011) (1)
- Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended? (2007) (1)
- Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants (2022) (1)
- Die Virologie von SARS-CoV-2 (2020) (1)
- 877 OXIDIZED LOW DENSITY LIPOPROTEIN (OXLDL) IS A PAN-GENOTYPE INHIBITOR OF HCV ENTRY THAT ACTS IN A SR-BI DEPENDENT MANNER (2012) (1)
- P211 HOST mTORC1 SIGNALING IS REQUIRED FOR HEPATITIS C VIRUS (HCV) RNA REPLICATION (2014) (0)
- Coronaviren : Von gewöhnlichen Atemwegsinfekten bis hin zum akuten Atemnotsyndrom ( ARDS ) (2020) (0)
- Sodium taurocholate cotransporting polypeptide (hNTCP) Varianten beeinflussen den HDV Zelleintritt aber nicht den antiviralen Effekt von Myrcludex-B (2018) (0)
- Inactivation of Hepatitis C Virus by Human Breastmilk (2013) (0)
- Machine learning on large scale perturbation screens for SARS-CoV-2 host factors identifies β-catenin/CBP inhibitor PRI-724 as a potent antiviral (2023) (0)
- Primary but not secondary biliary acids inhibit hepatitis D virus entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (2014) (0)
- 642 CHARACTERISATION OF HEPATITIS C VIRUS ENTRY AND RNA REPLICATION IN CELLS OF CNS ORIGIN (2010) (0)
- Comparison of automated extraction and amplification platforms on quantification of plasma HDV RNA: A multicenter study (2019) (0)
- Einfluss von Serum oxLDL auf die Infektiosität des Hepatitis C Virus in vitro und in vivo (2011) (0)
- „Hinschmeißen? Nein. Nie.“ (2021) (0)
- Identification of Z-Tyr-Ala-CHN2, a Cathepsin L Inhibitor with Broad-Spectrum Cell-Specific Activity against Coronaviruses, including SARS-CoV-2 (2023) (0)
- Living Repository of Millions of T and B Cell Receptor Sequences from Patients with COVID-19 (2020) (0)
- Identification of host cell requirements and antivrial targets for hepatitis D virus infection (2016) (0)
- Relevance of Resistance Against Direct Acting Antiviral Agents in Hepatitis C Virus Infection – What Technology do we Really Need in Clinical Practice? (2013) (0)
- 393 Impaired trail-dependent cytotoxicity of CD1C-positive dendritic cells in chronic hepatitis C virus infection (2004) (0)
- THU-049-Impaired adaptive immunity is an early event in liver cirrhosis preceding acute-on-chronic liver failure (2019) (0)
- Die Virologie von SARS-CoV-2 (2020) (0)
- Modulation of HCV reinfection by fibroblast growth factor-2 and other non-interferon mediators (2015) (0)
- Reply to Fabbris et al. A Viable Alternative. Comment on “Kohmer et al. Self-Collected Samples to Detect SARS-CoV-2: Direct Comparison of Saliva, Tongue Swab, Nasal Swab, Chewed Cotton Pads and Gargle Lavage. J. Clin. Med. 2021, 10, 5751” (2022) (0)
- Sustainable strategies against the COVID-19 pandemic in Germany in winter 2021/2022 | Strategies to contain the COVID-19 pandemic (0)
- Impact of genetic polymorphisms in the SCARB1 gene on hepatitis C virus (2015) (0)
- SARS-CoV-2 entry route impacts a range of downstream viral and cellular processes (2022) (0)
- O53 SERUM LEVELS OF THE ENDOGENOUS HCV ENTRY INHIBITOR OXIDIZED LDL (OXLDL) PREDICT SVR FOLLOWING INTERFERON-BASED THERAPY OF CHRONIC HEPATITIS C (2014) (0)
- GRAFT LOSS AFTER ORTHOTOPIC LIVER TRANSPLANTATION DUE TO THROMBOSIS AFTER EMERGENCY USE OF RECOMBINANT FACTOR VIIA: 132 (2008) (0)
- NO EVIDENCE FOR DRUG RESISTANCE BY IMINOSUGAR-BASED HCV ASSEMBLY INHIBITORS IN TISSUE CULTURE (2010) (0)
- Infektionen der Leber, der Gallenwege und des Pankreas (2020) (0)
- CULTURE LONG-TERM TREATMENT WITH IMINOSUGARS-BASED HCV ASSEMBLY INHIBITORS DOES NOT LEAD TO VIRAL BREAKTHROUGH IN TISSUE CULTURE (2011) (0)
- Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein (2022) (0)
- Impaired adaptive immunity is an early event in liver cirrhosis preceding acute-on-chronic liver failure (2019) (0)
- A novel mid-scale screening assay to identify compounds with anti-HDV activity (2017) (0)
- Virale Infektionen bei Lebertransplantierten (2020) (0)
- Oxidiertes Low Density Lipoprotein (oxLDL) – endogener HCV Eintritt Inhibitor und Prädiktor für SVR nach Interferon-basierter Therapie bei chronischer Hepatitis C (2015) (0)
- 1147 EFFECT OF GENETIC POLYMORPHISMS IN THE CD81 GENE ON HEPATITIS C VIRUS CELL ENTRY AND NEUTRALIZATION WITH ANTI-CD81 ANTIBODIES (2013) (0)
- SARS-CoV-2/COVID-19: Systematischer Review zu Anforderungen an die persönliche Schutzausrüstung bei primärem Patientenkontakt und Strukturierung des Operationsbereiches (2020) (0)
- Wenn die Leber mit der Haut kämpft: generalisiertes papulöses-bullöses Exanthem nach Lebertransplantation (2006) (0)
- Toll-like receptor 7 and 8 agonists as potent inhibitors of hepatitis delta virus infection (2020) (0)
- Recent signs imitating hypertrophic cardiomyopathyfive years after resection of a primary hepatocellular carcinoma (2008) (0)
- COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view (2021) (0)
- Comment on: Effects of cyclosporine on human dendritic cell subsets. Author's reply (2005) (0)
- 838 TWO METHODS TO IDENTIFY CLINICAL HCV ISOLATES FOR IN VITRO STUDIES (2012) (0)
- Is Olfactory Testing a Useful Diagnostic Tool to Identify SARS-CoV-2 Infections Early? A Cross-Sectional and Longitudinal Analysis (2023) (0)
- Anti-parietal cell autoantibodies (PCA) as serological marker of recurrent primary biliary cirrhosis after liver transplantation (2007) (0)
- Implementierung eines Betriebskonzeptes in einer HNO-Klinik imRahmen der SARS-CoV-2-Pandemie./ [Implementation of an operational concept in an ENT clinic in the context of the SARS-CoV-2 pandemic]. (2020) (0)
- Increasing but insufficient neutralizing activity against Omicron-BA.1 after a second booster dose of mRNA-1273 vaccine in chronic haemodialysis patients (2022) (0)
- Omicron-induced interferon signalling prevents influenza A virus infection (2022) (0)
- Thirty years of CMV seroprevalence—a longitudinal analysis in a German university hospital (2020) (0)
- Endogenous oxidized LDL levels predict treatment response in interferon-based therapy of chronic hepatitis C (2014) (0)
- IN VITRO AND IN VIVO INVESTIGATIONS ON THE EFFECTS OF CYCLOSPORINE ON HUMAN DENDRITIC CELL SUBSETS (2004) (0)
- [COVID-19-a multiorgan disease that is challenging the health care system]. (2020) (0)
- Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes (cid:1) § (2010) (0)
- SARS-CoV-2 Screening-Strategien für internationale Reiserückkehrende: Evaluation des Antigen-Schnelltests in Frankfurt am Main (2022) (0)
- Correction to: Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial (2023) (0)
- Respiratory viruses in medicolegal autopsies during the winter season 2021/2022: observations after reduction of coronavirus disease-19 (COVID-19) pandemic restrictions (2023) (0)
- Chemomebolisation und Lebertransplantation als kurative Therapie eines fortgeschrittenen malignen Haemangioendothelioms der Leber (2006) (0)
- Scientific Program and Speakers (2014) (0)
- Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022 (2023) (0)
- Einzelnukleotid-Polymorphismen in der Promotorregion von Cyclophilin A haben keinen EInfluss auf den natürlichen Verlauf einer Hepatitis C Virusinfektion (2013) (0)
- Die Virologie von SARS-CoV-2./ [The virology of SARS-CoV-2]. (2020) (0)
- Variants in the human PPIA gene render host cells refractory to hepatitis C virus infection by destabilization of the essential host factor cyclophilin A (2012) (0)
- Call for a pan-European COVID-19 response must be comprehensive – Authors' reply (2021) (0)
- Novel SARS-CoV-2 variants induce higher toxicity in cardiovascular cells (2021) (0)
- Polio type 2 and 3 eradication: Relevance to the immunity status of individuals living in Germany, 2005-2020. (2023) (0)
- Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study (2022) (0)
- 419 INACTIVATION OF HEPATITIS C VIRUS BY DISINFECTANTS AND HEAT (2009) (0)
- 866 INACTIVATION OF HEPATITIS C VIRUS BY HUMAN MOTHER'S MILK (2012) (0)
- 111 NEW APPROACH FOR THE IDENTIFICATION OF REPLICATION COMPETENT HCV ISOLATES DERIVED FROM PATIENT SERA (2010) (0)
- Chronic Liver Diseases (2015) (0)
- P108: Impact of genetic polymorphisms in the SCARB1 gene on hepatitis C virus (2015) (0)
- Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits? (2023) (0)
- SEC14L2 is not a reliable predictor of HCV replication fitness (2016) (0)
- Dysfunctional adaptive immunity in liver cirrhosis and acute-on-chronic liver failure is characterized by aberrant immune checkpoint expression and diminished cytokine secretion in T cells (2020) (0)
- Pediatrics and COVID-19. (2021) (0)
- Landscape of Public T Cell Receptors Associated with Recovery from COVID-19 (2020) (0)
- SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells (2023) (0)
- Diagnosis and managment of membranous Budd-Chiari syndrome (2008) (0)
- Single Nucleotide Polymorphisms (SNPs) im Scarb1 Gen und deren Bedeutung für eine Hepatitis C Virus Infektion (2016) (0)
- Sodium taurocholate cotransporting popypeptide variants modulate HDV entry according to their function as a bile acid transporter but do not influence the antiviral effect of Myrcludex-B (2018) (0)
- Hepatitis-C-Virus-Zellkulturmodelle : Neue Perspektiven für Forschung und Klinik (2008) (0)
- Das Hepatitis C Nichtstrukturprotein 2 ist ein zusätzlicher Angriffspunkt für die durch Ciclosporin A vermittelte Hemmung der HCV RNA Replikation (2009) (0)
- Charakterisierung der Hemmung des Hepatitis C Virus Zelleintritts durch in vitro generiertes und endogenes oxidiertes LDL (2013) (0)
- Mutations in HCV NS3 but no Sec14L2 variants alter HCV RNA replication of natural occuring viruses in cell culture (2018) (0)
- Steroide steigern die Hepatitis C Virus Infektiösität durch Modulation des Viruseintritts (2009) (0)
- Analyse der differentiellen Beeinflussung der HCV-Replikationsaktivität durch mTor-Inhibitoren mittels whole genome Analyse (2017) (0)
- Aktueller Stand der Lebertransplantation (2012) (0)
- Virusinaktivierung im Krankenhaus – wie stabil ist das Hepatitis C Virus? (2009) (0)
- Eingeschränkte TRAIL-abhängige Zytotoxizität myeloider dendritischer Zellen bei der chronischen Hepatitis C (2015) (0)
- Omicron‐induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection (2023) (0)
- COVID-19 – eine Multiorganerkrankung stellt das Gesundheitssystem auf die Probe (2020) (0)
- IMMUNOSUPPRESSIVE AGENTS AND THEIR INFLUENCE ON HCV RNA REPLICATION AND INFECTIVITY IN VITRO: 1942 (2008) (0)
- Virale Infektionen bei Lebertransplantierten (2020) (0)
- Sofosbuvir vermindert die Zellproliferation von Hepatozyten in vitro und in vivo (2017) (0)
- P104: Serum biomarker profile can predict the outcome of acute HCV infection (2015) (0)
- EInfluss antiretroviraler Medikamente auf das Hepatitis C Virus (2013) (0)
- 80 Millionen Meinungen (2021) (0)
- Hepatitis B, Immunsuppression und perioperative Tumorstrategien beeinflussen Rezidive des hepatozellulären Karzinoms nach Lebertransplantation (2005) (0)
- 3. Berliner Woche der Pathologie (2010) (0)
- [144] IDENTIFICATION OF ANTI-PARIETAL CELL AUTOANTIBODIES (PCA) AS SEROLOGICAL MARKER OF RECURRENT PRIMARY BILIARY CIRRHOSIS AFTER LIVER TRANSPLANTATION (2007) (0)
- 772 SINGLE NUCLEOTIDE POLYMORPHISMS IN HUMAN CYCLOPHILIN A AND THEIR INFLUENCE ON HCVRNA REPLICATION IN VITRO (2011) (0)
- Genotype-specific expression system of Hepatitis C Virus glycoproteins for efficient viral particle complementation (2013) (0)
- P103: Effect of endogenous ligands of the high densitiy lipoprotein‐receptor scavenger receptor class B type I on the replication cycle of the hepatitis C virus (2015) (0)
- Expanding the donor pool-decontamination of HCV RNA positive kidneys with methylene blue (2018) (0)
- A NOVEL IMMUNOSUPPRESSIVE FUNCTION OF ANTI-IL-2 RECEPTOR ANTIBODIES: IMPAIRMENT OF ANTIGEN UPTAKE AND T CELL STIMULATION OF HUMAN MYELOID DENDRITIC CELLS BY BASILIXIMAB IN VITRO AND IN VIVO (2004) (0)
- 872 IMPACT OF ANTI-RETROVIRAL AGENTS ON SUSCEPTIBILITY TO AND REPLICATION OF HEPATITIS C VIRUS IN VITRO (2012) (0)
- Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models (2023) (0)
- Oxidiertes low density lipoprotein (oxLDL) ist ein neuer Prädiktor des Therapieansprechens bei Interferon-basierter Therapie der chronischen Hepatitis C (2014) (0)
- Repurposing of the antibiotic nitroxoline for the treatment of mpox (2022) (0)
- Etablierung der Genomischen Erreger-Surveillance zur Stärkung des Pandemie- und Infektionsschutzes in Deutschland (2023) (0)
- Proteomics of SARS-CoV-2-infected host cells reveals therapy targets (2020) (0)
- Generation of a Sleeping Beauty transposon-based cellular system for rapid and sensitive identification of SARS-CoV-2 host dependency and restriction factors (2021) (0)
- Effekte der Leberzirrhose auf den Hepatitis C Virus Replikationszyklus (2016) (0)
- HBV-spezifische zelluläre Immunantworten bei der okkulten Hepatitis B nach Lebertransplantation (2006) (0)
- Suitability of Different Diagnostic Platforms for Virological Testing of Blood Samples from Cornea Donors (2022) (0)
- SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment (2022) (0)
- Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma (2022) (0)
- Effect of Hepatic Cirrhosis on the HCV Replication Cycle (2016) (0)
- Abstracts of the Annual Congress of the British Society for Immunology. December 6-10, 2010. Liverpool, United Kingdom. (2010) (0)
- BASIC—LIVER, PANCREAS, AND BILIARY TRACT Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus (2010) (0)
This paper list is powered by the following services:
Other Resources About Sandra Ciesek
What Schools Are Affiliated With Sandra Ciesek?
Sandra Ciesek is affiliated with the following schools:
